Description
What is IGF-1 LR3?
IGF-1 LR3 is an 83-amino-acid recombinant analog of insulin-like growth factor 1. It differs from native 70-residue IGF-1 by an arginine-for-glutamate substitution at position 3 and a 13-amino-acid N-terminal extension. These modifications sharply reduce affinity for IGF-binding proteins while retaining IGF-1-receptor agonism, giving a longer functional half-life and higher free-fraction potency in model systems.
How IGF-1 LR3 works (research context)
IGF-1 LR3 acts as an agonist of the IGF-1 receptor (IGF-1R), a receptor tyrosine kinase. Binding triggers receptor autophosphorylation and recruitment of IRS-1, activating the PI3K/Akt and Ras/MAPK cascades governing proliferation, survival, and protein synthesis. The Arg3 substitution and N-terminal extension disrupt the IGFBP-binding interface, so the analog circulates largely unbound and exhibits an extended functional half-life.
Research applications
- In-vitro study of IGF-1R signaling via PI3K/Akt and MAPK pathways
- Cell-culture proliferation and protein-synthesis research with sustained exposure
- Pre-clinical modeling of IGFBP-independent IGF-1 activity
- Comparative potency and half-life research versus native IGF-1
Key facts
- 83-amino-acid analog of native 70-residue IGF-1
- Features an Arg3 substitution plus a 13-residue N-terminal extension
- Greatly reduced IGFBP affinity versus native IGF-1
- Agonist of the IGF-1 receptor tyrosine kinase
Product specifications
- Class: Long-acting insulin-like growth factor 1 analog (IGF-1R agonist)
- Also known as: Long R3 IGF-1; Long [Arg3]-IGF-1
- Form: Lyophilized powder vial
- Purity: ≥ 99% (HPLC verified)
- Testing: Independent third-party HPLC + mass spectrometry
- Documentation: Certificate of analysis per batch
- Storage: Store lyophilized at -20C; reconstituted solution refrigerated at 2-8C; avoid freeze-thaw cycles.
For laboratory research use only. Not for human or veterinary use, consumption, diagnostic, or therapeutic purposes.








Nina Abramova (verified owner) –
Sustained PI3K/Akt signaling in culture confirmed the reduced IGFBP binding. Consistent, well-documented material.
Dr. Theo Vandenberg (verified owner) –
IGF-1 LR3 reconstituted clean and our IGF-1R autophosphorylation assay lit up as expected. COA listed 98.6% and the Arg3 analog mass matched on LC-MS.
Dr. Priya Venkat (verified owner) –
Proliferation assays were reproducible with low variance. Reliable long-acting IGF-1 reference for our work.
Gabriel Costa (verified owner) –
COA on the lot, mass spec matched the 83-residue analog. Fast cold-chain shipping.
B. Osei (verified owner) –
Quality is there. Avoid freeze-thaw as noted — it shipped cold and I aliquoted immediately. Worked great.